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     C.pneumoniae and C.psittaci both cause respiratory infections in human. detection  of  these  
organisms  in  tissue  culture  is  difficult  and serological  testing  is unreliable. There  are  no  
sensitive  and  reliable  tests  for  the  detection  of  these  organisms. The  polymerase  chain reaction  
(PCR  )  has  provided  an alternative  diagnostic  method  for the detection of these fastidious  
organisms. The aim of this study was to develop a PCR to detect C.pneumoniae and C.psittaci from 
clinical samples. The PCR was optimized in a series of experiments. To determine  if  the  optimized  
PCR  could  be applied  to  clinical samples, mock  positive specimen  were  produced by  adding  
chlamydiae  to  throat  swab  from  healthy  adults. The DNA was extracted by phenol/chloroform. 
When tested by PCR all the throat swabs were negative. However,  when  diluted  and  retested,  
many  of the  swabs  were  positive  and 10 IFU  of C.psittaci  and  100  IFU  of C.pneumoniae  could  
be   detected.  This  experiment  indicates  that  inhibitor  to  PCR  are  found  in  throat  swab  and  
further  work  is  needed   on  specimen  preparation.   The PCR was optimized in a series of 
experiments.    The  optimal  conditions  were  to  use  a two  segment  PCR  with  68°c  annealing  
and  polymerization  temperature, 2.0mM  Mgcl2,  0.2μM  primers  and  40  cycles. The  PCR   was  
highly  sensitive  and  could  detect  one  inclusion  forming  unit  with  both  C.pneumoniae   and  
C.psittaci  strains.  Two  human  strains  and  one   nonhuman   strain  of  C.pneumoniae   and   two  
avian   strains   and  three  mammalian   strains   of C.psittaci   were   used   to  determine   the 
specificity  of PCR. The PCR detected all these different strains.   C.trachomatis   strains   were not 
detected.  Various bacterial  strains, fungi  DNA,  and  human  DNA  were  negative  in  PCR  and no  
amplification  DNA  was  found   in  negative  controls.  
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INTRODUCTION 
     Chlamydiae are a group of obligate 
intracellular parasites. They are gram-negative 
bacteria [1] with a unique developmental 
cycle. These microorganisms cause variety of 
diseases in human and other animals. They are 
divided into four species, C.psittaci, 
C.trachomatis, C.pneumoniae and C.pecorum 
[2-4]. Chlamydia are obligate intracellular 
parasites unable to produce their own ATP and 
so are "energy parasites" of their host 
eukaryotic cell. The genome of chlamydiae is 
about one million base pair [5]. They have two 
distinct forms, the elementary body (EB) 
which is infectious and the reticulate body 
(RB) [6,7]. The cell wall in Chlamydia 
resembles that of gram-negative bacteria, but 
it has no peptidoglycan [8]. Rigidity in the 
chlamydiae is thought to be due to disulfide 
bonds cross linking the major outer membrane 
protein (MOMP) and other cystine rich 
proteins [9]. The MOMP DNA has been 
sequenced and has become one of the most 
useful targets for chlamydial polymerase chain 
reaction tests [10-13]. C.pneumoniae strain 
TWAR is a human pathogen that causes 
respiratory infections including pneumonia. It 
is transmitted from human to human [14], 
probably by inhalation. The serological testes 
are not reliable and ELISA produces many 
false positive results. PCR is potentially a 
specific and sensitive method for detection of 
organisims from clinical specimens. The aim 
of this project is to develop a PCR which can 
detect C.pneumoniae and C.psittaci from 
clinical specimens. 
 
MATERIALS AND METHODS 
     In this study Ten Chlamydia strains were 
used, C.pneumoniae (IOL-207Human, VR-
1310Human, N16Horse), C.psittaci 
6BCAvian, N352Avian, Fpn Pring cat, Gpic 
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Guinea pig, EAE Lx sheep, C.trachomatis E 
T181Human, L2Human. DNA was extracted 
from clinical samples using proteinase K 
digestion followed by phenol-chloroform 
extraction. The samples were digested with 
proteinase K (250μg/ml) and 0.5% SDS 
(sodium dodesilsulfate) then incubated in 
56°for 3 hours. An equal volume of 
phenol/chloroform was added, mixed and 
centrifuged for three minutes at 11000g.The 
aqueous layer was removed and then extracted 
once with a volume of chloroform. The 
aqueous layer was precipitated with 1/10 
volume of sodium acetate(3M pH 5.2)and 2 
volumes of 100% ethanol, mixed and left to 
precipitate at -20°C for 10 minutes. Then, it 
was centrifuged at 4°C at 52000g for 15 
minutes. The pellet was washed in 70% 
ethanol and re-centrifuged at 52000g for 15 
minutes. The precipitated DNA was dried, 
then re-suspended in 100μl of TE (10mM-
Tris/HCL pH 8.0, 1mM EDTA) and stored at 
4°C. Because of its exquisite sensitive one 
needs adequate care in procedures not 
introduce contaminating DNA in the different 
steps in setting up a PCR. In DNA free room, 
the reaction mixture was prepared which 
contained different components. In the 
following table the concentration of each 
component is demonstrated. 
Table 1 shows concentration of each 
component in the form of stock, 10 reaction 
mixture or final concentration. 
 
Table 1. PCR protocol 
 Stock concentration 10 Reaction 
Mixture 
Final concentration 
Primer cpnA 130 μg/ml 19μl 0.2μM 




20 mM 44μl 800μM 
MgCl2² 100mM 5.0μl 0.5mM 
Taq polymerase  5μ/μl 2.0μl 1.0u/100μl 









DDW 760μl  
¹Stock solution of dNTP(contained 5mM dATP,dCTP,dGTP,dTTP). Reaction mixture contained 200uM of each.  
²0.5mM MgCL2   per reaction from 100mM stock solution and 1.5mM magnesium chloride per reaction from buffer. 
 
      
All the PCR reagents were stored in -
20°C.The ten-reaction mixture was prepared 
and mixed well, divided into ten eppendorf  
tube, then two drops paraffin oil were added to 
prevent evaporation. The 10ul DNA per one 
reaction was added to each tube then was put 
in the (PHC2) Techno Ltd machine. Two tubes 
as negative and positive controls were utilized 
in our method containing 10μl DDW in 
negative control and in positive control 10μl 
of Chlamydia DNA. 
     
 
Table 2. The Initially PCR in 30 cycles  
 Temp Time Annealing Time Extension Time 
First cycle 94°C 7min 55°C 1min 72°C 0.5min 
2-29 cycles   92°C 2min 55°C 1min 72°C 0.5min 
30   cycle     
  
92°C 2min 55°C 1min 72°C 5min 
 
After optimization, the number of cycle and 
annealing temperature were changed to 40 
cycle and 68°C for annealing. The PCR with 
three segments was altered to two segments 
with combining the annealing and extension of 
the primers. 
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                   Table 3. PCR after optimazation 




First cycle 94°C 7min 68°C 1min 1min 
2-39 cycles 92°C 2min 68°C 1min 1min 
40   cycle 92°C 2min 68°C 1min 5min 
 
                     
      
The PCR with three segments was altered to 
two segments with combining the annealing 
and extension of the primers. 
 
ELECTROPHORESIS 
     PCR products were analyzed by agarose 
gel electrophoresis. The 1.2% agarose gels 
were made up in Tris –phosphate EDTA 
buffer (0.09M Tris-phosphates 0.002M EDTA 
pH 8.0). The samples were mixed with 5μl of 
loading buffer ( bromophenol blue 0.25% and 
40% sucrose) and were then loaded onto gel. 
The one Kbp ladder (BRL) was used as a 
marker. Then, gel was stained in ethidium 
bromide (1μg/ml of distilled water) for 30 
minutes and de-stained in distilled water. The 
gel was examined under UV light and 
photographed with Polaroid 667 film. 
 
RESULTS 
     Design of primers for Chlamydia PCR 
A PCR was designed in this study to detect 
both C.pneumoniae and C.psittaci. The 
MOMP gene was chosen as the target, as more 
is known about this gene than any other 
chlamydial gene. The MOMP gene in 
Chlamydia is composed of 4 variable domains 
flanked by conserved regions. The primers 
were chosen from the regions outside of 
variable domain I where there is minimal 
nucleotide variation. This region would be 
amplified as follows: 
 
I…………I…VDI…I…...…I…VDII…I………I…VDIII……I…………I…VDIV….I…I 
   
      Analysis of the MOMP nucleotide 
sequences predicted that the chosen primers 
CPnA, CPnB would bind to all different 
strains. After amplification with the above 
primers, a fragment with a predicted length of 
336bp for C.pneumoniae and 351bp fragment 
for C.psittaci would be produced. The PCR 
products could be differentiated by using a 
hybridization probe or by using restriction 
endonuclease analysis. The restriction 
endonuclease enzymes, by cleaving the DNA 
in specific restriction sites, would give 
different sizes of DNA fragment. Two 
enzymes, Pst and Dra III, could be used to cut 
the PCR product. Pst I cleaves C.pneumoniae 
to give one 78 bp fragment and one 258bp 
fragment. Dra III cleaves C.psittaci which 
produces one 62bp fragment and 289bp 
fragment. Therefore, C.pneumoniae could be 
differentiated from C.psittaci by the size of 
restriction fragments. 
 
              Table 4. Primer position 
Primer                      sequence                                                                       position 
CpnA 5'  CTCCTTACAAGCCTTGCCTGTAGGG  3'                               57-81 
CpnB 5'  GCGATCCCAAATGTTTAAGGC           3'                             393-373 
               Numbered from the A of the ATG start codon 
               The optimization of the PCR 
 
     
Experiments were conducted to find the 
optimal concentration of each component in 
the PCR. The different variables, primer 
concentration, MgCL2 concentration, cycle 
number and annealing temperature were 
changed to determine the optimal conditions. 
C.pneumoniae TWAR strain was used in these 
experiments. The PCR product was analyzed 
by agarose gel electrophoresis, and the results 
were obtained by the intensity of the products 
after staining with ethidium bromide. The 
primer concentration of 0.2μM had a good 
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yield and further increase in primer 
concentration did not produce more products. 
Figure 1 shows the titration of primers. The 
MgCL2 concentration with good yield was 
2.0mM. Figure2 shows the titration ofMgCL2 
concentration. The dNTP concentration in 
each reaction was 800uM(200uM for each 
nucleotide).The highest temperature that 
provided strong band was 68°C.Figure 3 
shows the sensitivity of the PCRat 3annealing 
tempreture. To anneal and the extend of 
primers at the same time to simplify the 
procedure. Therefore, the three steps of a PCR 
can be changed to two steps by combining the 
annealing temperature and extension of the 
primers. The yield of PCR product was 
improved when 40 cycles were used. Figure 4 
shows the effect of altering cycle number on 
the yield of PCR product. Also, Figure 5 
shows the optimized PCR with 2 segments and 





Figure1. Titration of primers CpnA and CpnB 
 
Lane1      3.6uM primer                        Lane6     0.1uM primer 
Lane2       1.6uM primer                       Lane7     0.05uM primer 
Lane3       0.8uM primer                       Lane 8     0.025uM primer 
Lane4       0.4uM primer                       lane 9      0.0125uM primer 
Lane5       0.2uM primer                       Lane 10   negative control 







Figure 2. Titration of MgCL2 Concentration 
Lane 1 without MgCL2                                Lane 6     2.5 mM       ״ 
Lane 2     0.5 mM      ״                                  Lane 7     3.0 mM       ״ 
Lane 3     1.0 mM    ״                                    Lane 8     3.5 mM       ״ 
Lane 4     1.5 mM    ״                                    Lane 9     4.0 mM      ״ 
Lane 5     2.0 mM    ״                                    Lane 10    negative    control 
Lane 11   1Kb ladder as a marker 
TWAR DNA was used with 2x 106 IFU  
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Figure 3. The sensitivity of the PCR at 3 annealing temperature a)68°C b)70°C c)71°C 
 
Lane 1.    100 x 106 IFU of C.Pneumoniae                   Lane 5.    6.25 x 106 IFU 
Lane 2.    50 x 106 IFU                                                  Lane 6.    Negative control 
Lane 3.    25 x 106 IFU                                                  Lane 7.   1Kb ladder as a marker 









Figure 4. Effect of altering cycle number on the yield of PCR product 
 
 
Lane 1      30 cycles                                 Lane 4     45 cycles 
Lane 2      35 cycles                                 Lane 5     50 cycles 
Lane 3      40 cycles                                 Lane 6     negative control 
Lane 7     1Kb ladder as a marker 
C.Pneumoniae DNA with 7.5 x 104 IFU 
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Figure 5. Optimized PCR with 2 segments and 40 cycles, 68°C annealing temperature and DNA from C.Pneumoniae (IOL-
207) 
 
Lane 1    7.5 x   106 IFU           Lane 6   1Kb ladder as a marker 
Lane 2    7.5 x   105 IFU           Lane 7   1.5 x 102     IFU 
Lane 3    7.5 x   104 IFU           Lane 8   1.5 x 10       IFU 
Lane 4    1.5 x   104 IFU           Lane 9    negative control 





Figure 6. The sensitivity of the optimized PCR in detecting TWAR DNA (IOL-207) 
 
Lane 1         104 IFU                                            Lane 5       100    IFU 
Lane 2         103IFU                                             Lane 6       10-1   IFU 
Lane 3         102 IFU                                            Lane 7       negative control   
Lane 4         101 IFU                                            Lane 8      1Kb ladder as marker 
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Figure 7. The sensitivity of the optimized PCR in detecting C.Psittaci (6BC) 
 
Lane 1             105   IFU                                     Lane 5      101 IFU 
Lane 2             104   IFU                                     Lane 6      1    IFU 
Lane 3             103   IFU                                     Lane 7      negative control 







Figure 8. Detection of C.Pneumoniae and C.psittaci strains using the optimized PCR 
 
Lane 1         6BC    DNA                 Lane 7       1Kb ladder as a marker 
Lane 2         N352   DNA                 Lane 8        IOL-207                         
Lane 3         EAE    DNA                 Lane 9        N16 DNA 
Lane 4         GPIC   DNA                Lane 10       VR 1310DNA    
Lane 5         Fpn     DNA                 Lane 11       negative control 
Lane 6         IOL-207                       Lane 12       1Kb ladder   
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Figure 9. Detection of C.Pneumoniae(IOL-207) ind C.Psittaci (6BC) 
 
Lane   1     103    IFU   From   C.Pneumoniae    
Lane   2     102    IFU   From C.Psittaci                                             
Lane   3     10      IFU   From    C.Psittaci   
Lane   4     103  
Lane   5     1        IFU   From    C.Psittaci      
Lane   6     11 1Kb ladder 
Lane   7     102    IFU   From C.Pneumoniae 
Lane   8     10 IFU 
Lane   9     1        IFU        ״                     
Lane   10   positive control 
 
Determination of sensitivity in PCR 
     The PCR sensitivity was evaluated by 
comparing the PCR result with infectivity. The 
DNA was diluted serially in distilled water 
and sensitivity of the PCR was one IFU as 
shown in Figures 6 and 7. 
 
Determining the specificity of Chlamydia 
PCR  
     The specificity of the PCR was determined 
by testing three strains of C.pneumoniae, five 
strains of C.psittaci and two strains of 
C.trachomatis. All the strains were positive 
and produced a band of the expected size 
(336bp). All the C.psittaci strains were also 
positive with 351bp. Figure 8 shows different 
strains of Chlamydia. 
     The specificity of the PCR was determined 
by testing throat swabs as shown in Figure 9. 
 
DISCUSSION 
     In this study polymerase chain reaction was 
developed to detect Chlamydia in throat 
swabs. The MOMP gene in different species 
was sequenced, and it showed there are 
regions with high degree of homology 
between the different species. We selected the 
primers from highly conserved regions of the 
MOMP gene which flanked variable domain 
I(VDI) which would be able to detect 
C.pneumoniae and C.psittaci. Tong and Sillis 
in 1993[15] used primers from same region of 
the MOMP gene in nested PCR with four 
primers. The optimization process showed a 
two-step PCR is a suitable method. The 
sensitivity was measured in term of infectivity 
(IFU), as it was assumed that in chlamydial 
one IFU represents one organism. A 
sensitiviry of one IFU was the aim, as other 
studies suggest that this level of sensitivity is 
required to be useful in a diagnostic situation. 
Tjhie et al. (1993) used PCR in detection of 
Chlamydia species using the MOMP gene as 
the target and also reported a sensitivity of one 
IFU after hybridization with a probe. The 
sensitivity of PCR in this study was equivalent 
to Tjhie’s studies but without hybridization. It 
also reported the same sensitivity of one IFU 
after hybridization with a probe [13]. In this 
study, the sensitivity of PCR was equivalent to 
Tjhie’s studies but without hybridization. The 
results from clinical samples indicated the 
presence of inhibitors which inhibits PCR. To 
overcome this, the samples were diluted ½ in 
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DDW, and were then retested by PCR. The 
sensitivity of PCR after dilution was 10 IFU 
for C.psittaci and 100IFU for 
C.pneumonia[16]. More recent studies have 
shown there is some variability in 
C.pneumoniae strains [10,17,18] and have 
reported variation in DNA sequences [19], 
antigenic variability and [20] morphology 
variation. The method for preparation of 
clinical samples is very important as others 
have found. In most of these studies proteinase 
K digestion was used to extract DNA, but in 
our study phenol/chloroform in addition to PK 
digestionwas used. The protainase K digestion 
and phenol/chloroform for DNA extraction 
were used.  
     Tjhie [13] used one freeze thaw step and 
boiling for 10 minutes, and then added DNA 
to PCR mixture. In most of these studies 
protainase K digestion was used to extract 
DNA, but in our study phenol/chloroform in 
addition to PK digestion was used. 
     It was thought that this would produce a 
clean DNA sample and have less problems 
with inhibitors. It is possible that it was 
residual phenol/chloroform in the DNA 
sample that affected the PCR and not 
inhibitors in the samples. Therefore, sample 
preparation needs more investigation to find 
the best method. PCR is an extremely 
sensitive and specific test which with further 
investigation of the specimen preparation 
could be used to test clinical samples. This 
method has the potential to be used as a rapid 
diagnostic test that would give a result in time 
to be helpful in choosing the antibiotic 
treatment for a patient with a respiratory 
illness. The PCR which is described here 
could be further developed into a multiplex 
PCR to simultaneously detect other 
microorganism such as Mycoplasma 
Pneumoniae, as well as Chlamydia in a single 
test. This type of multiplex test has great 
potential in the future as a screen for patients 
with atypical pneumonia. 
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